Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective study to evaluate the pharmacokinetics, clinical and virologic response
to acyclovir episodic therapy for genital herpes ulcers in HIV negative African women.
Phase:
N/A
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)